Cencora Current Ratio 2012-2026 | COR
Current and historical current ratio for Cencora (COR) from 2012 to 2026. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Cencora current ratio for the three months ending March 31, 2026 was 0.00.
| Cencora Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2026-03-31 | $53.14B | $56.13B | 0.95 |
| 2025-12-31 | $54.15B | $59.13B | 0.92 |
| 2025-09-30 | $52.24B | $57.82B | 0.90 |
| 2025-06-30 | $48.81B | $53.96B | 0.91 |
| 2025-03-31 | $46.54B | $53.33B | 0.87 |
| 2024-12-31 | $49.99B | $54.51B | 0.92 |
| 2024-09-30 | $47.72B | $54.28B | 0.88 |
| 2024-06-30 | $47.31B | $52.97B | 0.89 |
| 2024-03-31 | $44.16B | $49.76B | 0.89 |
| 2023-12-31 | $44.86B | $50.77B | 0.88 |
| 2023-09-30 | $42.80B | $48.83B | 0.88 |
| 2023-06-30 | $40.99B | $46.78B | 0.88 |
| 2023-03-31 | $39.99B | $45.07B | 0.89 |
| 2022-12-31 | $40.71B | $44.76B | 0.91 |
| 2022-09-30 | $39.59B | $43.48B | 0.91 |
| 2022-06-30 | $39.75B | $43.15B | 0.92 |
| 2022-03-31 | $39.41B | $42.80B | 0.92 |
| 2021-12-31 | $39.38B | $41.61B | 0.95 |
| 2021-09-30 | $38.80B | $41.36B | 0.94 |
| 2021-06-30 | $37.26B | $39.59B | 0.94 |
| 2021-03-31 | $35.47B | $33.00B | 1.08 |
| 2020-12-31 | $34.70B | $35.04B | 0.99 |
| 2020-09-30 | $33.06B | $33.85B | 0.98 |
| 2020-06-30 | $29.92B | $30.63B | 0.98 |
| 2020-03-31 | $31.18B | $32.11B | 0.97 |
| 2019-12-31 | $28.96B | $30.63B | 0.95 |
| 2019-09-30 | $28.13B | $29.58B | 0.95 |
| 2019-06-30 | $27.40B | $28.79B | 0.95 |
| 2019-03-31 | $27.62B | $29.21B | 0.95 |
| 2018-12-31 | $27.48B | $29.35B | 0.94 |
| 2018-09-30 | $25.89B | $27.87B | 0.93 |
| 2018-06-30 | $26.40B | $28.10B | 0.94 |
| 2018-03-31 | $26.40B | $28.09B | 0.94 |
| 2017-12-31 | $25.30B | $26.74B | 0.95 |
| 2017-09-30 | $24.30B | $26.82B | 0.91 |
| 2017-06-30 | $23.68B | $25.75B | 0.92 |
| 2017-03-31 | $23.49B | $25.53B | 0.92 |
| 2016-12-31 | $23.08B | $25.54B | 0.90 |
| 2016-09-30 | $22.85B | $25.28B | 0.90 |
| 2016-06-30 | $21.46B | $24.00B | 0.89 |
| 2016-03-31 | $22.07B | $23.77B | 0.93 |
| 2015-12-31 | $20.36B | $24.02B | 0.85 |
| 2015-09-30 | $20.33B | $21.58B | 0.94 |
| 2015-06-30 | $19.90B | $21.12B | 0.94 |
| 2015-03-31 | $19.56B | $20.23B | 0.97 |
| 2014-12-31 | $20.15B | $20.81B | 0.97 |
| 2014-09-30 | $16.80B | $17.25B | 0.97 |
| 2014-06-30 | $15.89B | $16.34B | 0.97 |
| 2014-03-31 | $15.76B | $16.50B | 0.96 |
| 2013-12-31 | $15.23B | $15.83B | 0.96 |
| 2013-09-30 | $14.39B | $14.87B | 0.97 |
| 2013-06-30 | $12.14B | $12.44B | 0.98 |
| 2013-03-31 | $11.73B | $12.04B | 0.97 |
| 2012-12-31 | $11.02B | $11.44B | 0.96 |
| 2012-09-30 | $11.06B | $11.27B | 0.98 |
| 2012-06-30 | $11.17B | $10.95B | 1.02 |
| 2012-03-31 | $11.60B | $10.92B | 1.06 |
| 2011-12-31 | $11.96B | $11.30B | 1.06 |
| 2011-09-30 | $11.38B | $10.88B | 1.05 |
| 2011-06-30 | $11.12B | $10.01B | 1.11 |
| 2011-03-31 | $10.96B | $9.95B | 1.10 |
| 2010-12-31 | $10.43B | $9.64B | 1.08 |
| 2010-09-30 | $10.75B | $9.91B | 1.09 |
| 2010-06-30 | $10.34B | $9.49B | 1.09 |
| 2010-03-31 | $10.17B | $9.43B | 1.08 |
| 2009-12-31 | $9.92B | $9.24B | 1.07 |
| 2009-09-30 | $9.95B | $9.48B | 1.05 |
| 2009-06-30 | $9.14B | $8.59B | 1.06 |
| 2009-03-31 | $9.01B | $8.48B | 1.06 |
| 2008-12-31 | $9.01B | $8.51B | 1.06 |
| 2008-09-30 | $8.67B | $8.17B | 1.06 |
| 2008-06-30 | $8.45B | $7.87B | 1.07 |
| 2008-03-31 | $8.81B | $8.24B | 1.07 |
| 2007-12-31 | $8.84B | $8.31B | 1.06 |
| 2007-09-30 | $8.94B | $7.86B | 1.14 |
| 2007-06-30 | $9.15B | $7.84B | 1.17 |
| 2007-03-31 | $9.88B | $8.19B | 1.21 |
| 2006-12-31 | $9.33B | $7.79B | 1.20 |
| 2006-09-30 | $9.21B | $7.46B | 1.24 |
| 2006-06-30 | $9.31B | $7.44B | 1.25 |
| 2006-03-31 | $9.21B | $7.13B | 1.29 |
| 2005-12-31 | $9.17B | $7.11B | 1.29 |
| 2005-09-30 | $7.99B | $6.05B | 1.32 |
| 2005-06-30 | $8.00B | $6.27B | 1.28 |
| 2005-03-31 | $8.25B | $6.55B | 1.26 |
| 2004-12-31 | $7.95B | $5.92B | 1.34 |
| 2004-09-30 | $8.30B | $6.10B | 1.36 |
| 2004-06-30 | $8.91B | $6.41B | 1.39 |
| 2004-03-31 | $9.15B | $6.70B | 1.37 |
| 2003-12-31 | $8.60B | $5.92B | 1.45 |
| 2003-09-30 | $8.86B | $6.26B | 1.42 |
| 2003-06-30 | $9.47B | $6.44B | 1.47 |
| 2003-03-31 | $9.31B | $6.59B | 1.41 |
| 2002-12-31 | $9.10B | $6.51B | 1.40 |
| 2002-09-30 | $8.35B | $6.10B | 1.37 |
| 2002-06-30 | $7.69B | $5.44B | 1.41 |
| 2002-03-31 | $7.84B | $5.72B | 1.37 |
| 2001-12-31 | $8.16B | $5.72B | 1.43 |
| 2001-09-30 | $7.51B | $5.53B | 1.36 |
| 2001-06-30 | $2.73B | $1.83B | 1.49 |
| 2001-03-31 | $2.63B | $1.94B | 1.36 |
| 2000-12-31 | $2.81B | $1.93B | 1.46 |
| 2000-09-30 | $2.32B | $1.75B | 1.33 |
| 2000-06-30 | $2.27B | $1.62B | 1.40 |
| 2000-03-31 | $1.97B | $1.41B | 1.40 |
| 1999-12-31 | $2.21B | $1.43B | 1.55 |
| 1999-09-30 | $1.92B | $1.33B | 1.45 |
| 1999-06-30 | $1.80B | $1.19B | 1.51 |
| 1999-03-31 | $1.58B | $1.07B | 1.48 |
| 1998-12-31 | $1.67B | $1.06B | 1.57 |
| 1998-09-30 | $1.42B | $1.02B | 1.40 |
| 1998-06-30 | $1.45B | $0.96B | 1.52 |
| 1998-03-31 | $1.51B | $0.94B | 1.61 |
| 1997-12-31 | $1.67B | $0.96B | 1.74 |
| 1997-09-30 | $1.63B | $1.13B | 1.44 |
| 1997-06-30 | $1.38B | $0.97B | 1.43 |
| 1997-03-31 | $1.40B | $0.87B | 1.62 |
| 1996-12-31 | $1.28B | $0.76B | 1.68 |
| 1996-09-30 | $1.12B | $0.79B | 1.42 |
| 1996-06-30 | $1.02B | $0.67B | 1.53 |
| 1996-03-31 | $1.01B | $0.69B | 1.47 |
| 1995-12-31 | $0.95B | $0.62B | 1.53 |
| 1995-09-30 | $0.77B | $0.53B | 1.46 |
| 1995-06-30 | $0.78B | $0.57B | 1.37 |
| 1995-03-31 | $0.78B | $0.50B | 1.57 |
| 1994-12-31 | $0.52B | $0.56B | 0.94 |
| 1994-09-30 | $0.65B | $0.52B | 1.24 |
| 1994-06-30 | $0.00B | 0.00 | |
| 1994-03-31 | $0.00B | 0.00 | |
| 1993-12-31 | $0.00B | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $62.409B | $321.333B |
| CENCORA INC is a healthcare solutions provider. CENCORA INC., formerly known as AmerisourceBergen, is based in CONSHOHOCKEN, Pa. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $134.187B | 24.31 |
| HCA Healthcare (HCA) | United States | $110.772B | 17.53 |
| CVS Health (CVS) | United States | $101.670B | 11.75 |
| Elevance Health (ELV) | United States | $68.432B | 10.33 |
| Natera (NTRA) | United States | $27.358B | 0.00 |
| Labcorp Holdings (LH) | United States | $21.501B | 15.87 |
| DiDi Global (DIDIY) | China | $18.026B | 15.96 |
| Viatris (VTRS) | United States | $15.685B | 5.71 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $14.535B | 0.00 |
| Medpace Holdings (MEDP) | United States | $14.094B | 32.26 |
| BioMerieux (BMXMF) | France | $12.476B | 0.00 |
| Solventum (SOLV) | United States | $11.408B | 10.78 |
| Revvity (RVTY) | United States | $10.039B | 17.71 |
| BrightSpring Health Services (BTSG) | United States | $8.774B | 43.59 |
| Charles River Laboratories (CRL) | United States | $8.667B | 17.09 |
| ICON (ICLR) | Ireland | $8.626B | 8.56 |
| CochLear (CHEOY) | Australia | $8.030B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $6.905B | 0.00 |
| HealthEquity (HQY) | United States | $6.586B | 23.20 |
| Bausch + Lomb (BLCO) | Canada | $5.877B | 32.98 |
| GETINGE (GNGBY) | Sweden | $5.626B | 17.96 |
| Avantor (AVTR) | United States | $5.388B | 8.68 |
| PACS (PACS) | United States | $5.304B | 27.44 |
| Caris Life Sciences,�Inc (CAI) | United States | $5.101B | 0.00 |
| Sotera Health (SHC) | United States | $4.380B | 19.95 |
| Alignment Healthcare (ALHC) | United States | $4.188B | 0.00 |
| Concentras Parent (CON) | United States | $2.818B | 16.12 |
| Organon (OGN) | United States | $2.299B | 2.57 |
| Amplifon S.p.A (AMFPF) | Italy | $2.275B | 13.27 |
| Pediatrix Medical (MD) | United States | $1.782B | 11.11 |
| Establishment Labs Holdings (ESTA) | United States | $1.765B | 0.00 |
| GeneDx Holdings (WGS) | United States | $1.746B | 42.28 |
| Surgery Partners (SGRY) | United States | $1.671B | 41.65 |
| Sonida Senior Living (SNDA) | United States | $1.544B | 0.00 |
| Ardent Health (ARDT) | United States | $1.345B | 5.70 |
| Progyny (PGNY) | United States | $1.277B | 25.08 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.240B | 0.00 |
| InnovAge Holding (INNV) | United States | $1.113B | 164.00 |
| Teladoc Health (TDOC) | United States | $0.920B | 0.00 |
| CareDx (CDNA) | United States | $0.822B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $0.750B | 12.17 |
| Enhabit (EHAB) | United States | $0.709B | 25.89 |
| Nutex Health (NUTX) | United States | $0.704B | 11.25 |
| Omada Health (OMDA) | United States | $0.672B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.604B | 99.85 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.531B | 0.00 |
| Embecta (EMBC) | United States | $0.524B | 2.92 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| CryoPort (CYRX) | United States | $0.482B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.435B | 4.70 |
| SBC Medicals (SBC) | United States | $0.426B | 8.47 |
| Forward Industries (FWDI) | United States | $0.375B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.349B | 0.00 |
| Agilon Health (AGL) | United States | $0.316B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.309B | 0.00 |
| Oncology Institute (TOI) | United States | $0.304B | 0.00 |
| So-Young (SY) | China | $0.262B | 0.00 |
| LifeMD (LFMD) | United States | $0.166B | 0.00 |
| Biodesix (BDSX) | United States | $0.133B | 0.00 |
| Beauty Health (SKIN) | United States | $0.115B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.091B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.080B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.077B | 0.00 |
| DocGo (DCGO) | United States | $0.051B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.037B | 0.00 |
| Pomdoctor - (POM) | China | $0.031B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.026B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.018B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.015B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.011B | 0.00 |
| Lifeward (LFWD) | United States | $0.010B | 0.00 |
| XWELL (XWEL) | United States | $0.009B | 0.00 |
| Aclarion (ACON) | United States | $0.007B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.007B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| Co-Diagnostics (CODX) | United States | $0.005B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |